BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 32546668)

  • 1. Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma.
    Lapidot Y; Amir A; Nosenko R; Uzan-Yulzari A; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Safran M; Ben-Ari Z
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32546668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
    Fukui H
    Diseases; 2019 Nov; 7(4):. PubMed ID: 31726747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
    Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
    Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma.
    Zhang L; Chen C; Chai D; Li C; Qiu Z; Kuang T; Liu L; Deng W; Wang W
    J Transl Med; 2023 Feb; 21(1):126. PubMed ID: 36793057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.
    Jinato T; Anuntakarun S; Satthawiwat N; Chuaypen N; Tangkijvanich P
    Appl Microbiol Biotechnol; 2024 Dec; 108(1):34. PubMed ID: 38183473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
    Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
    Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
    Effenberger M; Waschina S; Bronowski C; Sturm G; Tassiello O; Sommer F; Zollner A; Watschinger C; Grabherr F; Gstir R; Grander C; Enrich B; Bale R; Putzer D; Djanani A; Moschen AR; Zoller H; Rupp J; Schreiber S; Burcelin R; Lass-Flörl C; Trajanoski Z; Oberhuber G; Rosenstiel P; Adolph TE; Aden K; Tilg H
    Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
    Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
    Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion.
    Zhang N; Wang Z; Lv J; Zhang S; Liu Y; Liu T; Li W; Gong L; Zhang X; El-Omar EM; Lu W
    Front Med (Lausanne); 2022; 9():836369. PubMed ID: 35372388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysbiosis of gut microbiota due to diet, alcohol intake, body mass index, and gastrointestinal diseases in India.
    Sharma P; Singh S; Das K; Mahant S; Das R
    Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2547-2560. PubMed ID: 36929191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
    Piñero F; Vazquez M; Baré P; Rohr C; Mendizabal M; Sciara M; Alonso C; Fay F; Silva M
    Ann Hepatol; 2019; 18(3):480-487. PubMed ID: 31023615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis.
    Wu Z; Zhou H; Liu D; Deng F
    Front Cell Infect Microbiol; 2023; 13():1218552. PubMed ID: 37483387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
    Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
    Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma.
    Cho EJ; Leem S; Kim SA; Yang J; Lee YB; Kim SS; Cheong JY; Cho SW; Kim JW; Kim SM; Yoon JH; Park T
    Sci Rep; 2019 May; 9(1):7536. PubMed ID: 31101866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.
    Grąt M; Wronka KM; Krasnodębski M; Masior Ł; Lewandowski Z; Kosińska I; Grąt K; Stypułkowski J; Rejowski S; Wasilewicz M; Gałęcka M; Szachta P; Krawczyk M
    Transplant Proc; 2016 Jun; 48(5):1687-91. PubMed ID: 27496472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.
    Huang JH; Wang J; Chai XQ; Li ZC; Jiang YH; Li J; Liu X; Fan J; Cai JB; Liu F
    Microbiol Spectr; 2022 Oct; 10(5):e0098322. PubMed ID: 36173308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
    Shu W; Shanjian C; Jinpiao L; Qishui O
    Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
    Li F; Wang M; Wang J; Li R; Zhang Y
    Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosis.
    Oikonomou T; Cholongitas E; Gioula G; Minti F; Melidou A; Protonotariou E; Akriviadis E; Goulis I
    Hippokratia; 2020; 24(4):157-165. PubMed ID: 35023891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma.
    Ni J; Huang R; Zhou H; Xu X; Li Y; Cao P; Zhong K; Ge M; Chen X; Hou B; Yu M; Peng B; Li Q; Zhang P; Gao Y
    Front Microbiol; 2019; 10():1458. PubMed ID: 31293562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.